Polaris Capital boosted its Elevance Health stake by 37.3% in Q3 2025 amid strong earnings and revenue growth.

Polaris Capital Management increased its stake in Elevance Health (ELV) by 37.3% in Q3 2025, now holding 83,941 shares valued at about $27.1 million, while Tema Etfs LLC acquired 4,363 shares, raising its stake to 6,994. Elevance Health reported strong Q3 earnings on October 21, 2025, with $6.03 per share, beating estimates, and $50.09 billion in revenue, a 12% year-over-year rise. The company, based in Indianapolis and formerly Anthem, Inc., has a market cap of $83.36 billion, a P/E ratio of 15.33, and a dividend yield of 1.8%. Analysts maintain a “Hold” consensus rating with a $400.85 average price target.